DC-45-B2(81781-28-4)
- Name: DC-45-B2
- Synonyms:TrioxacarcinA, 7''-deoxo-7''-hydroxy-; Spiro[2,13-methano-10H-anthra[1,2-b]-1,3-dioxolo[4,5-d]pyran-14,2'-oxirane],trioxacarcin A deriv.; Antibiotic DC 45B2; Trioxacarcin C
- Molecular Formula:C42H54 O20
- Molecular Weight:878.96
- CAS Registry Number:81781-28-4
- EINECS:
- Melting Point:181.5°C (rough estimate)
- Water Solubility:
CAS No.81781-28-4 Spiro[2,13-methano-10H-anthra[1,2-b]-1,3-dioxolo[4,5-d]pyran-14,2'-oxiran]-10-one,7-[(4-O-acetyl-2,6-dideoxy-3-C-methyl-a-L-xylo-hexopyranosyl)oxy]-13-[[2,6-dideoxy-4-C-(1-hydroxyethyl)-a-L-xylo-hexop
Assay:99% Transportation:By sea Application:Pharmaceutical industry
Min. Order:0
Supplier:Antimex Chemical Limied [
China (Mainland)]
CAS No.81781-28-4 CAS 81781-28-4 H-anthra[1,2-b]-1,3-dioxolo[4,5-d]pyran-14,2'-oxiran]-10-one,7-[(4-O-acetyl-2,6-dideoxy-3-C-methyl-a-L-xylo-hexopyranosyl)oxy]-13-[[2,6-dideoxy-4-C-(1-hydroxyethyl)-a-L-xylo-hexop
Assay:99% Appearance:Colorless solid Package:A variety of packing ways for your choice Storage: Keep it in dry,shady and cool place Transportation:By sea Application:Pharmaceutical industry
Min. Order:1Kilogram
Supplier:Hubei Jiutian Bio-medical Technology Co., Ltd [
China (Mainland)]
CAS No.81781-28-4 Spiro[2,13-methano-10H-anthra[1,2-b]-1,3-dioxolo[4,5-d]pyran-14,2'-oxiran]-10-one,7-[(4-O-acetyl-2,6-dideoxy-3-C-methyl-a-L-xylo-hexopyranosyl)oxy]-13-[[2,6-dideoxy-4-C-(1-hydroxyethyl)-a-L-xylo-hexop
Assay:98.5% Appearance:white/off-white or light yellow Package:aluminum bottle,glass bottle,PTFE bottle,cardboard drum Storage:Store in cool and dry place, keep away from strong light and heat. Transportation:by courier, by air, by sea Application:This product can be used in food/pharmaceutical/cosmetical industry
Min. Order:0
Supplier:Suzhou Health Chemicals Co., Ltd. [
China (Mainland)]

Other Product
- 13637-83-7/ClO2F
- 172256-05-2/1-[(benzyloxy)methyl]-6-[(3,5-dimethylphenyl)selanyl]-5-ethylpyrimidine-2,4(1H,3H)-dione
- 935-44-4/1-PHENYL-1-CYCLOPROPANECARBONITRILE
- 75990-57-7/3-(4-bromophenyl)-3-hydroxy-2,2-dimethyl-1-phenyl-propan-1-one
- 33548-32-2/1-Methyl-6-oxo-1,4,5,6-tetrahydropyridazine-3-carboxylic acid
- 111-28-4/TRANS,TRANS-2,4-HEXADIEN-1-OL
- 144660-78-6/4-cyanotiazofurin
- 61196-55-2/4-[(3S,5R)-2,2-diethyl-5-phenylpyrrolidin-3-yl]pyridine dihydrochloride
- 25768-37-0/PN 609-21M
- 15467-31-9/2-(1H-indol-3-yl)-2-methylpropan-1-amine
- 42882-59-7/N-benzyl-2,3,3-trimethylbutan-2-amine hydrochloride (1:1)
- 200868-69-5/Sarcovagenine A
- 63098-95-3/1-ethyl-1-phenylurea
- 26916-48-3/Poly[imino(1-oxo-1,13-tridecanediyl)]
- 123963-51-9/5-((1-(5-Ethyl-5-hydroxy-1-methyl-3-heptenyl)octahydro-7a-methyl-4H-inden-4-ylidene)ethylidene)-4-methylene-1,3-cyclohexanediol (1R-(1alpha(1R*,3E),3abeta,4E(1R*,3S*,5Z),7aalpha))-
- 96874-51-0/N1,N2-dipentan-3-ylethanedihydrazide
- 96-34-4/Methyl chloroacetate
- 182868-38-8/8-bromo-1-cyclopropyl-7-(3,5-dimethylpiperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
- 91843-74-2/6-methyl-2-{(2E)-2-[(2-nitrophenyl)methylidene]hydrazino}pyrimidin-4(1H)-one
- 81781-28-4/DC-45-B2
- 875-51-4/4-Bromo-2-nitroaniline
- 158846-28-7/Benzoic acid,5-chloro-2-[[2-(hydrazinylcarbonyl)hydrazinyl]methoxy]-, hydrazide
- 72487-34-4/(R*,R*)-(1)-5-(1-Hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)salicylamide monohydrochloride
- 71720-84-8/Benzenesulfonic acid, ((9,10-dihydro-9,10-dioxo-1,4-anthracenediyl)diimino)bis((4-chlorophenoxy)-, disodium salt
- 823-69-8/7,7-Dichlorodicyclo[4.1.0]heptane
- 1392-84-3/Phaeofacin
- 13153-00-9/2-acetyl-N-phenylhydrazinecarbothioamide
- 5248-48-6/2-Ethyl-4-ethylamino-6-methoxy-1,3,5-triazine
- 68443-77-6/[hydroxyacetato(2-)-O1,O2](isooctadecanoato-O)(methacrylato-O)titanium
- 90294-13-6/24-Nor-6,7-secochola-14,20,22-trien-6-al, 7-((2-aminoethyl)imino)-21,23-epoxy-4,4,8-trimethyl3-oxo-, (5-beta,13-alpha,17-alpha)-